Delivering extraordinary. Empowering ordinary.
We’re developing novel oral medicines for rare diseases to help patients take part in the everyday activities they enjoy.
Learn MoreStructure-guided Drug Design
We combine traditional cell biology with medicinal chemistry to build synthetic compounds that bind to specific protein targets to fight disease.
See Our ScienceBuilding a Rare Disease Drug Portfolio
We are developing a pipeline of oral drugs for rare diseases.
View Our PipelineRecent News
Stay up to date with the latest discoveries, events, and reports from BioCryst.
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting
-
BioCryst Begins Enrollment in Pivotal APeX-P Trial Evaluating ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema
Join Our Team
We are a collection of passionate individuals united by a commitment to scientific excellence and an unwavering focus on the needs of patients.
JOB OPENINGS